Globe Life Inc. (NYSE:GL – Get Free Report) EVP Robert Edward Hensley sold 712 shares of the company’s stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $142.59, for a total transaction of $101,524.08. Following the completion of the sale, the executive vice president directly owned 8,580 shares in the company, valued at approximately $1,223,422.20. The trade was a 7.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.
Globe Life Stock Performance
Globe Life stock traded down $0.77 during midday trading on Friday, reaching $145.32. 504,950 shares of the company’s stock were exchanged, compared to its average volume of 513,973. The stock’s 50-day simple moving average is $141.76 and its 200 day simple moving average is $138.69. The firm has a market cap of $11.57 billion, a price-to-earnings ratio of 10.32 and a beta of 0.47. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.07 and a current ratio of 0.07. Globe Life Inc. has a 52 week low of $109.38 and a 52 week high of $152.71.
Globe Life (NYSE:GL – Get Free Report) last released its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The business had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period in the previous year, the business earned $3.14 earnings per share. The business’s quarterly revenue was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, analysts expect that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.
Globe Life Increases Dividend
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on GL shares. Weiss Ratings upgraded shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, February 13th. Morgan Stanley reissued an “overweight” rating and issued a $176.00 price target on shares of Globe Life in a report on Monday, December 15th. Truist Financial raised their price objective on shares of Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. Wells Fargo & Company upped their target price on Globe Life from $170.00 to $171.00 and gave the company an “overweight” rating in a research report on Wednesday. Finally, Piper Sandler reiterated an “overweight” rating and set a $167.00 target price on shares of Globe Life in a research note on Friday, November 21st. Eight investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $171.33.
Read Our Latest Stock Report on Globe Life
Key Globe Life News
Here are the key news stories impacting Globe Life this week:
- Positive Sentiment: Board raised the quarterly dividend to $0.33 (22.2% increase) and announced two new board members — supports income-focused investors and signals confidence in cash flow. GLOBE LIFE INC. DECLARES DIVIDEND AND ANNOUNCES APPOINTMENT OF TWO NEW BOARD MEMBERS
- Positive Sentiment: Wells Fargo published a positive price-forecast note on Globe Life, which can attract buyers and lend near-term support to the share price. Wells Fargo & Company Issues Positive Forecast for Globe Life (NYSE:GL) Stock Price
- Neutral Sentiment: Globe Life Field booked for an Eagles concert, which forced a local high school to reschedule prom — shows strong event demand and venue utilization but has minimal direct impact on insurance operations. Eagles concert at Globe Life Field moves Texas high school’s prom night date How an Eagles concert at Globe Life Field bumped a North Texas high school prom
- Neutral Sentiment: GL was included in a Zacks piece highlighting high-ROE stocks as resilient plays; such coverage may raise investor interest but is not a company-specific catalyst. Buy 5 Stocks With High ROE as Markets Dance Whimsically to the AI Tune
- Negative Sentiment: CEO James Matthew Darden sold 9,527 shares (~15% reduction in his reported ownership), a sizable insider sale that can spook some investors. SEC Form 4 – Darden sale
- Negative Sentiment: EVP Robert Edward Hensley sold 712 shares (~7.7% reduction in his holding), another insider sale that adds to selling pressure signals. SEC Form 4 – Hensley sale
- Negative Sentiment: TipRanks flagged Globe Life’s rising allocation to alternative assets as increasing volatility, capital strain and liquidity risk — a potential medium-term headwind for valuation if realized. Globe Life’s Growing Alternative Asset Bets Raise Volatility, Capital Strain and Liquidity Risk
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Norges Bank bought a new position in shares of Globe Life during the second quarter worth approximately $157,722,000. Northwestern Mutual Wealth Management Co. grew its position in Globe Life by 34,786.0% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock worth $123,345,000 after buying an additional 879,391 shares in the last quarter. AQR Capital Management LLC increased its stake in Globe Life by 98.6% during the 2nd quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock worth $174,340,000 after acquiring an additional 696,548 shares during the period. Balyasny Asset Management L.P. acquired a new position in Globe Life in the 3rd quarter valued at $80,925,000. Finally, Westfield Capital Management Co. LP acquired a new position in Globe Life in the 3rd quarter valued at $61,569,000. Institutional investors and hedge funds own 81.61% of the company’s stock.
About Globe Life
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Recommended Stories
- Five stocks we like better than Globe Life
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
